Novel theranostic agent targets multiple cancer types

by Society of Nuclear Medicine and Molecular ImagingCredit: CC0 Public DomainA newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumor uptake, sustained tumor retention

Updated on: January 13,2024 13

Novel theranostic agent targets multiple cancer types

by Society of Nuclear Medicine and Molecular ImagingCredit: CC0 Public DomainA newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumor uptake, sustained tumor retention

Updated on:January 13,2024 13

New study discovers pre-treatment cognitive impairment in younger cancer patients

byUniversity of California, IrvineCredit: Unsplash/CC0 Public DomainA team of researchers led by the University of California, Irvine has discovered that adolescent and young adult cancer

Updated on: January 15,2024 14

New study discovers pre-treatment cognitive impairment in younger cancer patients

byUniversity of California, IrvineCredit: Unsplash/CC0 Public DomainA team of researchers led by the University of California, Irvine has discovered that adolescent and young adult cancer

Updated on:January 15,2024 14

Novel risk score for cardiovascular complications after bone marrow transplant

by Noah Fromson,University of Michigan3D Model of the heart by Dr. Matthew Bramlet. Credit: NIHFor thousands of Americans each year, a bone marrow transplant has the potential to cure diseases s

Updated on: March 20,2024 12

Novel risk score for cardiovascular complications after bone marrow transplant

by Noah Fromson,University of Michigan3D Model of the heart by Dr. Matthew Bramlet. Credit: NIHFor thousands of Americans each year, a bone marrow transplant has the potential to cure diseases s

Updated on:March 20,2024 12

Study identifies molecular basis of resistance to one of the main treatments for multiple myeloma

by The Spanish National Cancer Research CentreCredit: Pixabay/CC0 Public DomainMultiple myeloma is a type of cancer that affects plasma cells, the blood cells involved in the production of antibo

Updated on: February 01,2024 10

Study identifies molecular basis of resistance to one of the main treatments for multiple myeloma

by The Spanish National Cancer Research CentreCredit: Pixabay/CC0 Public DomainMultiple myeloma is a type of cancer that affects plasma cells, the blood cells involved in the production of antibo

Updated on:February 01,2024 10

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Updated on: January 04,2024 9

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Updated on:January 04,2024 9

Study identifies biomarker that may predict treatment response to chemoimmunotherapy

by Keck School of Medicine of USCAn artist’s depiction of a T cell. Credit: NIAIDCutting-edge cancer treatments like immunotherapy are offering new hope for patients, often in combination with mo

Updated on: January 29,2024 11

Study identifies biomarker that may predict treatment response to chemoimmunotherapy

by Keck School of Medicine of USCAn artist’s depiction of a T cell. Credit: NIAIDCutting-edge cancer treatments like immunotherapy are offering new hope for patients, often in combination with mo

Updated on:January 29,2024 11

Blood test for brain cancer may be on horizon, research finds

byPennsylvania State UniversityCredit: Pixabay/CC0 Public DomainGlioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at

Updated on: January 23,2024 14

Blood test for brain cancer may be on horizon, research finds

byPennsylvania State UniversityCredit: Pixabay/CC0 Public DomainGlioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at

Updated on:January 23,2024 14

Everything You Need to Know About Blood Sugar Tests

Everything You Need to Know About Blood Sugar TestsByRachael Zimlich, BSN, RNPublished on January 10, 2022Medically reviewed byDo-Eun Lee, MDDiabetes is a chronic condition tha

Updated on: March 17,2024 0

Everything You Need to Know About Blood Sugar Tests

Everything You Need to Know About Blood Sugar TestsByRachael Zimlich, BSN, RNPublished on January 10, 2022Medically reviewed byDo-Eun Lee, MDDiabetes is a chronic condition tha

Updated on:March 17,2024 0

Trial results show PARP inhibitor benefit in 'BRCA-like' breast cancer

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free surviva

Updated on: January 04,2024 8

Trial results show PARP inhibitor benefit in 'BRCA-like' breast cancer

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free surviva

Updated on:January 04,2024 8

Exercise protects breast cancer patients' hearts against chemotherapy drugs, new study finds

by Baker Heart & Diabetes InstituteCredit: Unsplash/CC0 Public DomainCardiovascular disease is the leading cause of mortality in breast cancer survivors. A new study out of the Baker Heart and Dia

Updated on: January 15,2024 10

Exercise protects breast cancer patients' hearts against chemotherapy drugs, new study finds

by Baker Heart & Diabetes InstituteCredit: Unsplash/CC0 Public DomainCardiovascular disease is the leading cause of mortality in breast cancer survivors. A new study out of the Baker Heart and Dia

Updated on:January 15,2024 10

Two genomic studies could yield more effective, less toxic immunotherapies

by Institut CurieTE-Exon splicing junctions can help differentiate tumors from healthy tissue. Credit: Verge Scientific Communications / Antonela Merlotti / Marianne Burbage / Benjamin SadaccaMnemo Th

Updated on: December 28,2023 10

Two genomic studies could yield more effective, less toxic immunotherapies

by Institut CurieTE-Exon splicing junctions can help differentiate tumors from healthy tissue. Credit: Verge Scientific Communications / Antonela Merlotti / Marianne Burbage / Benjamin SadaccaMnemo Th

Updated on:December 28,2023 10

Researchers target mutation that leads to pancreatic cancer

by Leslie Cantu,Medical University of South CarolinaCrystal structures of 12D5(K63S) in complex with KRAS(G12D)•GTPγS and with KRAS(G12D)•GDP. (A) A comparison of 12D5(K63S)–KRAS(G12D)•GTPγS (Le

Updated on: February 20,2024 20

Researchers target mutation that leads to pancreatic cancer

by Leslie Cantu,Medical University of South CarolinaCrystal structures of 12D5(K63S) in complex with KRAS(G12D)•GTPγS and with KRAS(G12D)•GDP. (A) A comparison of 12D5(K63S)–KRAS(G12D)•GTPγS (Le

Updated on:February 20,2024 20